117 related articles for article (PubMed ID: 5926171)
1. Interaction of aromatic amines with rat liver proteins in vivo. I. Preferential labeling of a cytoplasmic protein or proteins by N-2-fluorenyl-acetamide-9-14C.
Barry EJ; Gutmann HR
J Biol Chem; 1966 Oct; 241(20):4600-9. PubMed ID: 5926171
[No Abstract] [Full Text] [Related]
2. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
Barry EJ; Malejka-Giganti D; Gutmann HR
Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
[No Abstract] [Full Text] [Related]
3. Interaction of aromatic amines with rat liver proteins in vivo. II. Binding of N-2-fluorenylacetamide-9-14C to nuclear proteins.
Barry EJ; Ovechka CA; Gutmann HR
J Biol Chem; 1968 Jan; 243(1):51-60. PubMed ID: 5635948
[No Abstract] [Full Text] [Related]
4. ENZYMATIC N-HYDROXYLATION OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE AND THE METABOLISM OF N-HYDROXY-2-ACETYLAMINOFLUORENE-9-14C IN VITRO.
IRVING CC
J Biol Chem; 1964 May; 239():1589-96. PubMed ID: 14193833
[No Abstract] [Full Text] [Related]
5. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo.
Kriek E
Chem Biol Interact; 1969 Oct; 1(1):3-17. PubMed ID: 5407054
[No Abstract] [Full Text] [Related]
6. The carinogenicity of N-hydroxy-N-2-fluorenyl-acetamide and the matabolism of N-2-fluorenyl-acetamide in Praomis (mastomys) natalensis.
Yamamoto RS; Pai SR; Korzis J; Weisburger JH
Br J Cancer; 1968 Dec; 22(4):769-75. PubMed ID: 4303104
[No Abstract] [Full Text] [Related]
7. THE BIOLOGICAL ARYLATION OF PROTEINS IN VITRO BY A METABOLITE OF THE CARCINOGEN N-2-FLUORENYLACETAMIDE.
NAGASAWA HT; OSTERAAS AJ
Biochem Pharmacol; 1964 May; 13():713-23. PubMed ID: 14181274
[No Abstract] [Full Text] [Related]
8. Protein modifications by activated carcinogens. I. The acetylation of ribonuclease by N-acetoxy-2-fluorenylacetamide.
Barry EJ; Gutmann HR
J Biol Chem; 1973 Apr; 248(8):2730-7. PubMed ID: 4697389
[No Abstract] [Full Text] [Related]
9. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities.
Lower GM; Bryan GT
Biochem Pharmacol; 1973 Jul; 22(13):1581-8. PubMed ID: 4729805
[No Abstract] [Full Text] [Related]
10. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
Gutmann HR; Erickson RR
J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
[No Abstract] [Full Text] [Related]
11. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver.
Bartsch H; Dworkin M; Miller JA; Miller EC
Biochim Biophys Acta; 1972 Dec; 286(2):272-98. PubMed ID: 4660457
[No Abstract] [Full Text] [Related]
12. Protein labelling by 2-imino-1, 2-fluorenoquinone, a metabolite in vitro of the carcinogen N-(2-fluorenyl) acetamide.
GUTMANN HR; KING CM
Biochim Biophys Acta; 1962 Jan; 56():394-6. PubMed ID: 13903197
[No Abstract] [Full Text] [Related]
13. Methylation of nucleic acids by N[14C]-methyl-N-nitrosourethane in vitro and in vivo.
Schoental R
Biochem J; 1967 Jan; 102(1):5C-7C. PubMed ID: 6030301
[No Abstract] [Full Text] [Related]
14. Modifications of ribonucleic acid by chemical carcinogens. II. In vivo reaction of N-2-acetylaminofluorene with rat liver ribonucleic acid.
Agarwal MK; Weinstein IB
Biochemistry; 1970 Feb; 9(3):503-8. PubMed ID: 5415957
[No Abstract] [Full Text] [Related]
15. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
[No Abstract] [Full Text] [Related]
16. EFFECTS OF CARCINOGENIC AMINES ON AMINO ACID INCORPORATION BY LIVER SYSTEMS. 3. INHIBITION BY AMINOFLUORENE TREATMENT AND ITS DEPENDENCE ON VITAMIN E.
HULTIN T; ARRHENIUS E
Cancer Res; 1965 Feb; 25():124-31. PubMed ID: 14264044
[No Abstract] [Full Text] [Related]
17. Preferential binding of 2-acetylaminofluorene to rat liver rRNA during early stages of hepatocarcinogenesis.
Irving CC; Veazey RA
Biochem Biophys Res Commun; 1972 Jun; 47(5):1159-64. PubMed ID: 5029863
[No Abstract] [Full Text] [Related]
18. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
[No Abstract] [Full Text] [Related]
19. Difference in binding of 2-acetylaminofluorene to rat liver deoxyribonucleic acid and ribosomal ribonucleic acid in vivo.
Kriek E
Biochim Biophys Acta; 1968 Jun; 161(1):273-5. PubMed ID: 4298436
[No Abstract] [Full Text] [Related]
20. On the mechanism of action of carcinogenic aromatic amines. II. Binding of N-hydroxy-N-acetyl-4-aminobiphenyl to rat-liver nucleic acids in vitro.
Kriek E
Chem Biol Interact; 1971 Feb; 3(1):19-28. PubMed ID: 5156323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
